From cancer research to challenges beyond the reach of traditional AI, four UK start-ups are using quantum technologies to bring new innovations to market.
The start-ups have joined the DeepTech Catalyst Quantum incubator programme (DTC Quantum), where they will use quantum technologies to develop and commercialise new products designed to deliver practical, real-world benefits.
DTC Quantum is led by the Science and Technology Facilities Council (STFC) in collaboration with the UK Research and Innovation (UKRI) National Quantum Computing Centre (NQCC) at the Harwell Science and Innovation Campus, Oxfordshire.
The programme supports start-ups working at the forefront of quantum technology, through access to cutting-edge research facilities, technical expertise, targeted funding and tailored business support.
Its goal is to turn promising ideas into practical applications, accelerating the journey from early concept to commercial success.
Meet the quantum innovators
The following UK start-ups are joining the DTC Quantum.
Curenetics
Accelerating the search for new cancer treatments.
By combining quantum technology with artificial intelligence (AI), its system identifies the most promising and safe cancer vaccine targets faster than traditional methods, potentially cutting years off development timelines.
Coherence Engine
Helping make quantum computers easier to build and scale.
Its software enables engineers to design and test control systems in a virtual environment before using real hardware, saving time and reducing risk.
AmorphiQ
Tackling data problems too complex for standard AI.
By blending quantum computing with AI, it can solve complex data challenges, such as predicting material degradation and financial market forecasting.
Qascade
Developing ultra-fast, low energy ways to move data using light instead of electricity.
This could help data centres and future quantum systems run more efficiently and at greater scale.